Routine blood tests should not be used for surveillance of patients in remission from aggressive lymphoma because they have little value in detecting relapse, Victorian oncologists say. A study of 346 patients in remission from aggressive lymphoma found that none of the routine lab tests – including erythrocyte sedimentation rate (ESR), lactate dehydrogenease (LDH), Full ...
No role for routine blood tests in detecting relapse of lymphoma
By Michael Woodhead
25 Jul 2018